Home / News

News

Catch up on the latest news and press releases about CMS – the firm, latest developments and insights from our publications. Read all about the newest developments in the legal industry. If you are a journalist or media representative looking for commentary on the legal implications of trends and developments in the business world, please visit our global press room.



Expertise
26/09/2022
Glob­al LSHC For­um 2022 | Press re­lease
Un­cer­tain times, an evolving leg­al frame­work: man­aging risks and en­sur­ing so­cial re­spons­ib­il­ity in the life sci­ences & health­care sec­tor The risks of AI in the fu­ture of life sci­ences will come un­der the mi­cro­scope at a land­mark leg­al for­um this week.Health­care is ra­cing ahead in ad­opt­ing new tech­no­lo­gies across drug dis­cov­ery, de­vel­op­ment, man­u­fac­tur­ing and sup­ply chain but ex­perts pre­dict a tail-whip of dis­putes and con­tract fric­tion.Di­git­al trans­form­a­tion has the po­ten­tial to im­prove every as­pect of health­care and the pharma in­dustry but it also im­pacts data pro­tec­tion, IT se­cur­ity, con­tract design, li­ab­il­ity and reg­u­la­tion.The an­nu­al CMS Glob­al Life Sci­ences and Health­care For­um will bring to­geth­er high-level in­dustry and leg­al ex­perts to dis­cuss sec­tor in­tel­li­gence and best prac­tice as well as is­sues ran­ging from cy­ber breaches and crypto­cur­rency wrangles to fall-outs over trade secrets and in­tel­lec­tu­al prop­erty (IP).“AI of­fers amaz­ing op­por­tun­it­ies to ad­vance life sci­ences and ush­er in trans­form­at­ive medi­cine such as cell and gene ther­apy, im­proved dia­gnostics and ana­lyt­ics but it also comes with con­cerns as leg­al and con­trac­tu­al risks are still be­ing un­der­stood and eval­u­ated,” says Nick Beck­ett, Glob­al Co-Head of CMS Life Sci­ences & Health­care Sec­tor Group“Sci­ence and tech­no­logy are mov­ing for­ward very quickly but we are find­ing that the de­tail and strategy of what to do to mit­ig­ate risks or re­solve them is lag­ging be­hind. These are crit­ic­ally im­port­ant is­sues that com­pan­ies need to ad­dress and the For­um will ex­am­ine the im­plic­a­tions and solu­tions.”AI is boom­ing and a re­cent re­port by ana­lysts  Grand View Re­search fore­cast that the glob­al AI in health­care mar­ket will grow from its cur­rent value of $10.4 bil­lion at a com­pound an­nu­al growth rate (CAGR) of 38.4% from 2022 to 2030. AI is fast be­com­ing a sig­ni­fic­ant ele­ment of every as­pect of health­care and leg­al de­part­ments and busi­ness units are be­ing chal­lenged to re­spond.The For­um, which is be­ing held in Brus­sels and on­line on Thursday, Septem­ber 28, has a packed agenda cov­er­ing tech­no­logy trans­form­a­tion, En­vir­on­ment­al, Sus­tain­ab­il­ity and Gov­ernance, sup­ply chain dis­rup­tion, reg­u­lat­ory frame­works and the chan­ging com­mer­cial land­scape.The scale of chal­lenge was evid­enced in the re­cent CMS Tech­no­logy Trans­form­a­tion: Man­aging Risks in a Chan­ging Land­scape re­port which re­vealed that 56% of cor­por­ate coun­sel and risk man­agers ex­pect an in­crease in AI-re­lated dis­putes, while 50% be­lieve that the use of AI tech­no­lo­gies will lead to risks and dis­putes that can­not cur­rently be fore­seen.Dis­putes will be driv­en by is­sues arising from IP and trade secrets, the use of AI, smart con­tracts, crypto­cur­ren­cies and cloud ser­vices, they be­lieve. “Or­gan­isa­tions are likely to see new types of risks and dis­putes emerge from the use of new tech­no­lo­gies such as AI and crypto­cur­ren­cies. Many busi­nesses are play­ing catch-up in un­der­stand­ing the risks as­so­ci­ated with these new tech­no­lo­gies,” says Lee Gluyas, Part­ner, CMS. “Whilst no busi­ness can elim­in­ate risks com­pletely, those that think ahead, plan early and act­ively man­age risk will give them­selves a sub­stan­tial ad­vant­age.” The free to at­tend For­um will fea­ture key­note speak­ers from the United Na­tions Health and De­vel­op­ment Team, gen­er­al coun­sel from lead­ing pharma com­pan­ies, Bo­ston Con­sult­ing Group, fin­an­cial ser­vices mul­tina­tion­al Aon and CMS sec­tor spe­cial­ists.For fur­ther de­tails or to at­tend, re­gister here: ht­tps://cms.law/en/int/events/glob­al-life-sci­ences-health­care-for­um-2022.
22/09/2022
Boom and gloom? European M&A Out­look 2023
M&A ex­pect­a­tions run high: Al­most all re­spond­ents (88%) are cur­rently con­sid­er­ing M&A.Un­der­val­ued tar­gets and dis­tressed sales to drive activ­ity: The biggest buy-side driver of M&A is ex­pec­ted to be the...
11/08/2022
News in Sus­tain­ab­il­ity Claims
CMS Green Globe
21/07/2022
CMS re­cords year of strong growth in 2021
CMS, a lead­ing glob­al law firm, today an­nounces rev­en­ues for the fin­an­cial year Janu­ary-Decem­ber 2021 of EUR 1.746bn.The res­ults re­flect a pos­it­ive year for CMS, trans­lat­ing in­to year-on-year growth of...
28/06/2022
Tech­no­logy Trans­form­a­tion: Man­aging Risks in a Chan­ging Land­scape
AI is a key area of growth for cor­por­ates but will bring an in­creased risk of dis­putes The types of dis­putes ex­pec­ted over the next three years are dif­fer­ent to the past three and re­flect de­vel­op­ments...
21/06/2022
CMS ap­points six new prac­tice and sec­tor group heads
CMS is pleased to an­nounce new heads for four of its in­ter­na­tion­al ex­pert­ise groups.All CMS law­yers work in cross-bor­der groups across more than 40 coun­tries world­wide that are struc­tured ac­cord­ing to...
13/06/2022
CMS European Real Es­tate Deal Point Study 2022
Real es­tate in­vest­ment mar­kets re­main stable whilst buy­ers con­tin­ue to catch up in con­trac­tu­al risk al­loc­a­tion Lo­gist­ics as­sets more pop­u­lar than ever De­mand from in­ter­na­tion­al in­vestors reaches re­cord...
31/05/2022
New Europe-wide ana­lys­is provides in­sights in­to GDPR fin­ing and en­force­ment...
GDPR fines ex­ceeded EUR 1.5bn and 1,000 cases in 2021, ac­cord­ing to a new Europe-wide ana­lys­is – and there is more to come The total amount of pub­lished fines re­lated to non-com­pli­ance with the GDPR...
12/04/2022
CMS pro­motes 60 to part­ner­ship in re­cord-break­ing year for glob­al pro­mo­tions
In­ter­na­tion­al law firm CMS is pleased to an­nounce the pro­mo­tion of 60 new part­ners, rep­res­ent­ing the firm’s largest-ever glob­al pro­mo­tions round. The ap­point­ments span 33 cit­ies across Europe, the Middle...
06/04/2022
CMS Al­bania has ad­vised 4IG on the ac­quis­i­tion of One Tele­com­mu­nic­a­tions...
CMS has as­sisted 4iG on the in­dir­ect ac­quis­i­tion of One Tele­com­mu­nic­a­tions, upon ac­quir­ing all the shares in the Bul­gari­an com­pany Al­bania Tele­com In­vest. One Tele­com­mu­nic­a­tions is a ma­jor tele­com­mu­nic­a­tion...
23/03/2022
CMS: European M&A bounced back to pre-pan­dem­ic levels, with a re­turn...
23 March 2022 – 2021 saw European M&A boom­ing, with a con­fid­ent re­turn to pre-pan­dem­ic levels and nor­mal deal be­ha­viour re­sum­ing in the ma­jor­ity of trans­ac­tions, ac­cord­ing to the latest an­nu­al M&A study...
17/03/2022
First USPP un­der Bel­gian law for Biobest
Biobest, a world lead­er in pol­lin­a­tion and in­teg­rated bio­lo­gic­al con­trol, has suc­cess­fully is­sued its first USPP gov­erned by Bel­gian law, which was sub­scribed by Pri­coa Private Cap­it­al, a lead­ing U.S...